Morphic Therapeutic Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 121

Employees

  • Stock Symbol
  • MORF

Stock Symbol

  • Share Price
  • $26.16
  • (As of Tuesday Closing)

Morphic Therapeutic General Information

Description

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Corporate Office
  • 35 Gatehouse Drive, A2
  • Waltham, MA 02451
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Morphic Therapeutic Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$26.16 $26.12 $19.34 - $62.08 $1.31B 50M 436K -$3.50

Morphic Therapeutic Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,059,305 714,240 663,712 1,323,665
Revenue 0 521 70,808 19,794
EBITDA (191,969) (177,593) (62,536) (94,784)
Net Income (161,254) (152,095) (59,041) (95,542)
Total Assets 682,765 722,514 368,589 426,290
Total Debt 3,281 2,344 3,838 5,049
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Morphic Therapeutic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Morphic Therapeutic‘s full profile, request access.

Request a free trial

Morphic Therapeutic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeli
Drug Discovery
Waltham, MA
121 As of 2023
00000
00000000 00000

000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000000
San Francisco, CA
000 As of 0000
00000
000000000000 00000

000000

lamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
000000000000000
West Conshohocken, PA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Morphic Therapeutic Competitors (72)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pliant Therapeutics Formerly VC-backed San Francisco, CA 000 00000 000000000000 00000
Madrigal Pharmaceuticals Corporation West Conshohocken, PA 000 00000 00000000 00000
Galectin Therapeutics Corporation Norcross, GA 00 000000000000
Aileron Therapeutics Formerly VC-backed Watertown, MA 0 00000 000000000 00000
Liminal Biosciences Private Equity-Backed Laval, Canada 00 00000 000000000000 00000
You’re viewing 5 of 72 competitors. Get the full list »

Morphic Therapeutic Executive Team (10)

Name Title Board Seat Contact Info
Praveen Tipirneni MD President, Chief Executive Officer and Board Membe
Bruce Rogers Ph.D Chief Scientific Officer
Marc Schegerin Chief Financial Officer, Finance & Chief Operating Officer, Operations
Robert Farrell Jr. Chief Accounting Officer, Senior Vice President, Finance & Operations and Treasurer
William DeVaul JD General Counsel, Legal & Secretary, Administration
You’re viewing 5 of 10 executive team members. Get the full list »

Morphic Therapeutic Board Members (16)

Name Representing Role Since
Amir Nashat Ph.D Polaris Partners Board Member 000 0000
Gustav Christensen Morphic Therapeutic Board Member 000 0000
Joseph Slattery Self Board Member 000 0000
Martin Edwards MD Morphic Therapeutic Board Member 000 0000
Nilesh Kumar Ph.D Novo Holdings Board Member 000 0000
You’re viewing 5 of 16 board members. Get the full list »

Morphic Therapeutic Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Morphic Therapeutic Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Morphic Therapeutic‘s full profile, request access.

Request a free trial

Morphic Therapeutic ESG

Risk Overview

Risk Rating

Updated May, 24, 2023

27 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,191

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.0

Percentile

Biotechnology

Subindustry

00 of 405

Rank

00.00

Percentile

To view Morphic Therapeutic’s complete esg history, request access »

Morphic Therapeutic FAQs

  • When was Morphic Therapeutic founded?

    Morphic Therapeutic was founded in 2014.

  • Who is the CEO of Morphic Therapeutic?

    Praveen Tipirneni MD is the CEO of Morphic Therapeutic.

  • Where is Morphic Therapeutic headquartered?

    Morphic Therapeutic is headquartered in Waltham, MA.

  • What is the size of Morphic Therapeutic?

    Morphic Therapeutic has 121 total employees.

  • What industry is Morphic Therapeutic in?

    Morphic Therapeutic’s primary industry is Drug Discovery.

  • Is Morphic Therapeutic a private or public company?

    Morphic Therapeutic is a Public company.

  • What is Morphic Therapeutic’s stock symbol?

    The ticker symbol for Morphic Therapeutic is MORF.

  • What is the current stock price of Morphic Therapeutic?

    As of 18-Jun-2024 the stock price of Morphic Therapeutic is $26.16.

  • What is the current market cap of Morphic Therapeutic?

    The current market capitalization of Morphic Therapeutic is $1.31B.

  • Who are Morphic Therapeutic’s competitors?

    Pliant Therapeutics, Madrigal Pharmaceuticals, Galectin Therapeutics, Aileron Therapeutics, and Liminal Biosciences are some of the 72 competitors of Morphic Therapeutic.

  • What is Morphic Therapeutic’s annual earnings per share (EPS)?

    Morphic Therapeutic’s EPS for 12 months was -$3.50.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »